EMBC
Embecta Corp.
Key Financials
Operating Income
$242.1M
↑ 45.1%
Revenue
$1.1B
↓ 3.8%
Gross Profit
$676.8M
↓ 7.9%
Net Income
$95.4M
↑ 21.8%
EPS (Diluted)
$1.62
↑ 20.9%
Shareholders' Equity
$-650600000.00
↑ 11.9%
Long-term Debt
$1.4B
↓ 11.2%
Total Assets
$1.1B
↓ 15.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/2/2026 | View on SEC |
| SCHEDULE 13G/A | 5/27/2026 | View on SEC |
| SD | 5/22/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/5/2026 | View on SEC |
| 10-Q | 5/5/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| SCHEDULE 13G/A | 5/1/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EMBC |
| Company Name | Embecta Corp. |
| CIK | 1872789 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | 8624010000 |